Philips Respironics, a subsidiary of Philips Healthcare, has initiated a voluntary worldwide recall of about 600 Trilogy ventilators due to a potentially defective component on the power management board.
According to a recall notice posted to the FDA’s website recently, the devices contain a potentially defective ferrite component on the power management board, which could cause the ventilator to fail. Additionally, the functionality of the alarm may be reduced to indicate ventilator failure, resulting in serious adverse health consequences or death, the company said.
No deaths or injuries related to the problem have been reported, Philips said.
The FDA has made it clear that developing a successful CAPA program has never been more important. But creating a compliant CAPA isn’t easy.
Register now for FDAnews and Immel Resources’ Conducting ADVANCED Root Cause Analysis and CAPA Investigations.
Learn how to respond to the FDA and implement effective CAPAs to prevent regulatory action and get a closeout letter, Register today.